Related Experiment Video
Updated: Jul 11, 2025

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
Published on: January 7, 2019
Amplifying mRNA vaccines: potential versatile magicians for oncotherapy
Chaoying Hu1,2,3, Jianyang Liu1,2,3, Feiran Cheng1,2,3
1Division of Hepatitis and Enterovirus Vaccines, National Institutes for Food and Drug Control, Beijing, China.
Abstract:
Cancer vaccines drive the activation and proliferation of tumor-reactive immune cells, thereby eliciting tumor-specific immunity that kills tumor cells. Accordingly, they possess immense potential in cancer treatment. However, such vaccines are also faced with challenges related to their design and considerable differences among individual tumors. The success of messenger RNA (mRNA) vaccines against coronavirus disease 2019 has prompted the application of mRNA vaccine technology platforms to the field of oncotherapy. These platforms include linear, circular, and amplifying mRNA vaccines. In particular, amplifying mRNA vaccines are characterized by high-level and prolonged antigen gene expression at low doses. They can also stimulate specific cellular immunity, making them highly promising in cancer vaccine research. In this review, we summarize the research progress in amplifying mRNA vaccines and provide an outlook of their prospects and future directions in oncotherapy.
Insights
Amplifying messenger RNA (mRNA) vaccines show promise for cancer treatment by stimulating potent anti-tumor immunity. This review explores their progress and future potential in oncotherapy.
Area of Science:
- Oncology
- Immunology
- Biotechnology
Background:
- Cancer vaccines aim to activate immune cells against tumors, but face design challenges and tumor heterogeneity.
- Messenger RNA (mRNA) vaccine technology, successful in infectious disease, is now being explored for cancer treatment (oncotherapy).
Purpose of the Study:
- To review research progress on amplifying mRNA vaccine platforms for cancer therapy.
- To provide an outlook on the future prospects and directions of amplifying mRNA vaccines in oncotherapy.
Main Methods:
- Review of current research on linear, circular, and amplifying mRNA vaccine platforms.
- Analysis of amplifying mRNA vaccines' characteristics, including antigen expression and immune stimulation.
Main Results:
- Amplifying mRNA vaccines offer high-level, prolonged antigen expression at low doses.
- These vaccines demonstrate the ability to stimulate specific cellular immunity, crucial for cancer vaccine efficacy.
Conclusions:
- Amplifying mRNA vaccines are highly promising for cancer vaccine research due to their unique characteristics.
- Further research and development are needed to realize their full potential in oncotherapy.
Related Concept Videos
Tumor Immunotherapy
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Microorganisms in Medicine and Therapeutics
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...

